RS 15385-198

CAS No. 121961-55-5

RS 15385-198( —— )

Catalog No. M36153 CAS No. 121961-55-5

RS 15385-198 is a less active isomer of Delequamine. Delequamine is a selective alpha2-adrenergic receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 321 In Stock
10MG 459 In Stock
25MG 718 In Stock
50MG 958 In Stock
100MG 1274 In Stock
200MG 1721 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RS 15385-198
  • Note
    Research use only, not for human use.
  • Brief Description
    RS 15385-198 is a less active isomer of Delequamine. Delequamine is a selective alpha2-adrenergic receptor antagonist.
  • Description
    RS 15385-198 is a less active isomer of Delequamine. Delequamine is a selective alpha2-adrenergic receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    121961-55-5
  • Formula Weight
    350.48
  • Molecular Formula
    C18H26N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(C)(=O)(=O)N1[C@@]2(C[C@@]3(C=4C(=CC(OC)=CC4)CCN3C[C@@]2(CCC1)[H])[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (3aR,9aR)-Fluparoxan

    (3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.

  • Deriglidole

    Deriglidole (SL 86-0715) is a peripheral adrenergic receptor antagonist that is a selective inhibitor of alpha2 receptors.

  • Besipirdine hydrochl...

    Besipirdine hydrochloride is a non-receptor-dependent cholinomimetic compound with alpha-adrenergic and cardiovascular activities.